Exendin-4, a stable synthetic form of GLP-1, is commonly used clinically for diabetes treatment because GLP-1 has a short half-life (Drucker and Nauck, 2006; Heppner et al., 2015b). The gene discussed is GCG; the disease is diabetes mellitus.